Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system-Reference-Cited by-同舟云学术

Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system

Published:2022-10-01 Issue:4 Volume:187 Page:619-622
ISSN:1365-2133
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

Cucka Bethany¹^ORCID,Biglione Bianca¹^ORCID,Zhou Li²³,Phillips Elizabeth J.⁴,Bassir Fatima²,Samarakoon Upeka⁵,Rrapi Renajd¹^ORCID,Chand Sidharth¹^ORCID,Wang Liqin²³,Alvarez-Arango Santiago⁶⁷,Blumenthal Kimberly G.⁵,Kroshinsky Daniela¹

Affiliation:

1. Department of Dermatology Massachusetts General Hospital Boston MA USA

2. Division of General Internal Medicine, Department of Medicine Brigham and Women’s Hospital Boston MA USA

3. Harvard Medical School Boston MA USA

4. Center for Drug Safety and Immunology, Department of Medicine Vanderbilt University Medical Center Nashville TN USA

5. Division of Rheumatology, Allergy and Immunology, Department of Medicine Massachusetts General Hospital Boston MA USA

6. Division of Clinical Pharmacology, Department of Medicine Johns Hopkins University School of Medicine Baltimore MD USA

7. Division of Allergy and Clinical Immunology, Department of Medicine Johns Hopkins University School of Medicine Baltimore MD USA

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.21706

Reference8 articles.

1. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?;Kardaun;Br J Dermatol,2007

2. Incidence of suspected serious adverse drug reactions in corona virus disease-19 patients detected by a pharmacovigilance program by laboratory signals in a tertiary hospital in Spain: cautionary data;Ramírez;Front Pharmacol,2020

3. Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19;Ramirez;Clin Microbiol Infect,2021

4. The DRESS syndrome: a literature review;Cacoub;Am J Med,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced Hypersensitivity Syndrome / Drug Reaction with Eosinophilia and Systemic Symptoms. Part I. Epidemiology, Pathogenesis, Clinicopathological Features, and Prognosis.;Journal of the American Academy of Dermatology;2023-07

2. Antibiotics hypersensitivity reactions during COVID-19 pandemic;Russian Journal of Infection and Immunity;2023-06-26

3. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses;Microorganisms;2023-01-30

4. Cefepime/meropenem/vancomycin;Reactions Weekly;2022-10-29